Cargando…

Chemotherapy for non‐Hodgkin lymphoma in the hemodialysis patient: A comprehensive review

Chemotherapy for non‐Hodgkin lymphoma (NHL) in the hemodialysis (HD) patient is a challenging situation. Because many drugs are predominantly eliminated by the kidneys, chemotherapy in the HD patient requires special considerations concerning dose adjustments to avoid overdose and toxicities. Conver...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yasuda, Hajime, Yasuda, Mutsuko, Komatsu, Norio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253291/ https://www.ncbi.nlm.nih.gov/pubmed/33938097 http://dx.doi.org/10.1111/cas.14933

Ejemplares similares

Hodgkin Lymphoma on Hemodialysis Successfully Treated with Extended Courses of Brentuximab Vedotin
por: Uchimura, Ayana, et al.
Publicado: (2022)

Radiation-Induced Myopathy Developing in a Hodgkin Lymphoma Patient: An Autopsy Case with Systemic Muscle Sampling
por: Ando, Jun, et al.
Publicado: (2021)

Splenic Marginal Zone Lymphoma with Prominent Myelofibrosis Mimicking Triple-Negative Primary Myelofibrosis
por: Tsutsui, Miyuki, et al.
Publicado: (2019)

Non-Hodgkin's lymphoma: A review
por: Singh, Rohit, et al.
Publicado: (2020)

Non-Hodgkin's Lymphomas
por: Proctor, S.J.
Publicado: (1994)

Systematic review of perchloroethylene and non-Hodgkin's lymphoma
por: Goodman, Julie E., et al.
Publicado: (2022)

Occurrence of sarcoidosis after chemotherapy for non-Hodgkin lymphoma
por: Cho, Hyungwoo, et al.
Publicado: (2016)

Management of Non-Hodgkin's Lymphoma in Maxillofacial Region with Chemotherapy
por: Moin, Ayesha, et al.
Publicado: (2017)

Diffuse Large B-cell Lymphoma with Adrenal Involvement Presenting as Other Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorders: Sustained Remission with Methotrexate Termination Alone in Two Cases
por: Yasuda, Hajime, et al.
Publicado: (2022)

Epidemiology of Non-Hodgkin’s Lymphoma
por: Thandra, Krishna C., et al.
Publicado: (2021)

Surgery for Non-Hodgkin’s Lymphoma
por: Weledji, Elroy Patrick, et al.
Publicado: (2015)

Resolution of One-Year Persisting COVID-19 Pneumonia and Development of Immune Thrombocytopenia in a Follicular Lymphoma Patient With Preceding Rituximab Maintenance Therapy: A follow-up Report and Literature Review of Cases With Prolonged Infections
por: Yasuda, Hajime, et al.
Publicado: (2021)

Male fertility after VAPEC-B chemotherapy for Hodgkin's disease and non-Hodgkin's lymphoma.
por: Radford, J. A., et al.
Publicado: (1994)

Novel Targeted Agents in Hodgkin and Non-Hodgkin Lymphoma Therapy
por: Grover, Natalie S., et al.
Publicado: (2015)

Hodgkin Reed–Sternberg-Like Cells in Non-Hodgkin Lymphoma
por: Parente, Paola, et al.
Publicado: (2020)

Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin Lymphoma
por: Vakkalanka, Bhanu, et al.
Publicado: (2011)

Combined chemotherapy in 76 children with non-Hodgkin's lymphoma excluding Burkitt's lymphoma.
por: Büyükpamukçu, M., et al.
Publicado: (1987)

Combination chemotherapy for intermediate and high grade non-Hodgkin's lymphoma.
por: Dhaliwal, H. S., et al.
Publicado: (1993)

Development of Hepatic Steatosis After Chemotherapy for Non‐Hodgkin Lymphoma
por: Ben‐Yakov, Gil, et al.
Publicado: (2018)

Bendamustine in the treatment of non-Hodgkin’s lymphomas
por: Hagemeister, Fredrick, et al.
Publicado: (2009)

Rituximab in the treatment of non-Hodgkin’s lymphoma
por: Hauptrock, Beate, et al.
Publicado: (2008)

Non-Coding RNAs in Hodgkin Lymphoma
por: Cordeiro, Anna, et al.
Publicado: (2017)

Drug Resistance in Non-Hodgkin Lymphomas
por: Klener, Pavel, et al.
Publicado: (2020)

The cost-effectiveness of high dose chemotherapy in the treatment of relapsed Hodgkin's disease and non-Hodgkin's lymphoma
por: Beard, S M, et al.
Publicado: (2000)

FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
por: Barrington, Sally F., et al.
Publicado: (2017)

Chemotherapy and echocardiographic indices in patients with non-Hodgkin lymphoma: the ONCO-ECHO study
por: Mizia-Stec, Katarzyna, et al.
Publicado: (2017)

Classical Hodgkin Lymphoma: From Past to Future—A Comprehensive Review of Pathophysiology and Therapeutic Advances
por: Munir, Faryal, et al.
Publicado: (2023)

Primary Non-Hodgkin Uterine Lymphoma of the Cervix: A Literature Review
por: Capsa, Cristina, et al.
Publicado: (2022)

Pharmacogenetics of anticancer drugs in non-Hodgkin lymphomas
por: Loni, L, et al.
Publicado: (2001)

SNPs Array Karyotyping in Non-Hodgkin Lymphoma
por: Etebari, Maryam, et al.
Publicado: (2015)

Current Immunotherapy Approaches in Non-Hodgkin Lymphomas
por: Pytlik, Robert, et al.
Publicado: (2020)

Sarcoid Reactions after Chemotherapy for Hodgkin’s Lymphoma
por: Wirk, Baldeep
Publicado: (2010)

The New Treatment Methods for Non-Hodgkin Lymphoma in Pediatric Patients
por: Derebas, Justyna, et al.
Publicado: (2022)

Fludarabine-containing chemotherapy for patients with previously untreated low-grade non-Hodgkin's lymphoma
por: Ahn, Jae-Sook, et al.
Publicado: (2011)

Non-Hodgkin Lymphoma Secondary to Hodgkin Lymphoma in an Adult Patient With Nijmegen Breakage Syndrome
por: Braitsch, Krischan, et al.
Publicado: (2018)

Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma
por: Chang, Sun Hee, et al.
Publicado: (2015)

Nutrition status and Helicobacter pylori infection in patients receiving hemodialysis
por: Sugimoto, Mitsushige, et al.
Publicado: (2018)

Hepatic Sinusoidal Obstruction Syndrome Induced by Non-transplant Chemotherapy for Non-Hodgkin Lymphoma
por: Sakumura, Miho, et al.
Publicado: (2017)

Consolidative proton therapy after chemotherapy for patients with Hodgkin lymphoma
por: Hoppe, B. S., et al.
Publicado: (2017)

Persistent COVID-19 Pneumonia and Failure to Develop Anti-SARS-CoV-2 Antibodies During Rituximab Maintenance Therapy for Follicular Lymphoma
por: Yasuda, Hajime, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uq1fek486nfm10sho26fjloj20